NON DISINTEGRATING TABLET FORMULATIONS DESIGNED

Brand Owner Address Description
MODAS ELAN CORPORATION, PLC Lincoln House Lincoln Place Dublin 2 Ireland non-disintegrating tablet formulations designed to control the absorption of highly water soluble drugs sold as an integral component of various oral pharmaceuticals in the nature of antacids, antispasmodics and anti-ulcerants, laxatives, anti-diarrhoeals, colorectal agents, cardiac drugs, drugs for the treatment of disorders of the central nervous system, CNS stimulants, analgesics, antipyretics and anti-inflammatory agents, muscle relaxants, hormonal, enzymal and steroidal preparations, drugs affecting bone metabolism, drugs affecting the genito-urinary system, diuretics and anti-diuretics, anti-infectives, anti-virals and immunological agents, electrolytes, vitamins and anabolic agents, bronchodilators, anti-asthmatics, expectorants, anti-tussives, decongestants, mucolytics and respiratory stimulants, oropharyngeal, aural and ocular preparations, anti-allergic drugs, hypo-sensitizing preparations, local and general anesthetics, oral and transdermal contraceptives, pharmaceutical preparations for the treatment of dermatological disorders, antineoplastic pharmaceutical preparations for inhibiting or preventing the growth and spread of neoplasms or malignant cells, and medical diagnostic reagents for administration in humans;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A tablet, obtainable by direct comprising the active ingredient 4-amino-1-hydroxybutylidene-1,1-bis-phosphonic (alendronic) acid or its pharmaceutically acceptable salts in an amount of 5 to 140 mg, based on the pure acid, a dry binder, a disintegrating agent, a lubricant, the tablet comprising, as the diluent, a combination of at least two diluents except lactose.